| 2026/03 - 人民幣(K¥) | 與去年末期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 6,280 | 0.00% | 6,280 | 6,353 | 6,500 | 0 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 0 |
| 固定資產 | 856,740 | -2.64% | 880,000 | 955,906 | 849,035 | 461,656 |
| 在建工程 | 1,578 | -- | 0 | 3,041 | 112,254 | 523,346 |
| 無形資產 | 14,799 | -5.80% | 15,711 | 17,514 | 15,376 | 17,233 |
| 商譽 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動資產 | 592,881 | 1.42% | 584,587 | 556,768 | 569,205 | 563,729 |
| 1,472,278 | -0.96% | 1,486,578 | 1,539,581 | 1,552,371 | 1,565,965 | |
流動資產 | ||||||
| 貨幣資金 | 513,320 | -55.40% | 1,151,045 | 1,001,327 | 1,039,366 | 651,463 |
| 應收賬款 | 1,193,572 | -2.61% | 1,225,517 | 1,298,879 | 1,410,519 | 1,287,074 |
| 存貨 | 150,712 | 7.03% | 140,807 | 176,882 | 173,536 | 153,646 |
| 其他流動資產 | 576,434 | 9,794.16% | 5,826 | 10,913 | 33,476 | 52,918 |
| 2,434,039 | -3.53% | 2,523,195 | 2,488,001 | 2,656,897 | 2,145,100 | |
流動負債 | ||||||
| 短期借款 | 30,106 | -78.48% | 139,896 | 186,889 | 190,914 | 109,296 |
| 應付票據 | 790 | -- | 0 | 938 | 4,000 | 17,804 |
| 應付帳款 | 11,341 | 284.18% | 2,952 | 4,966 | 3,129 | 16,338 |
| 其他流動負債 | 266,309 | -10.17% | 296,472 | 373,577 | 483,682 | 468,270 |
| 308,546 | -29.77% | 439,321 | 566,369 | 681,725 | 611,708 | |
| 流動資產淨值 | 2,125,493 | 2.00% | 2,083,875 | 1,921,632 | 1,975,173 | 1,533,392 |
| 資產總額減流動負債 | 3,597,771 | 0.77% | 3,570,452 | 3,461,213 | 3,527,543 | 3,099,357 |
非流動負債 | ||||||
| 長期借款 | 0 | -- | 0 | 0 | 0 | 15,748 |
| 應付債券 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動負債 | 32,948 | -0.14% | 32,993 | 13,705 | 13,492 | 7,941 |
| 32,948 | -0.14% | 32,993 | 13,705 | 13,492 | 23,689 | |
總權益 | ||||||
| 實收股本 | 129,947 | 0.00% | 129,947 | 132,947 | 134,650 | 134,650 |
| 儲備項目 | 3,434,876 | 0.80% | 3,407,513 | 3,314,562 | 3,379,401 | 2,941,018 |
| 股東權益 | 3,564,823 | 0.77% | 3,537,460 | 3,447,509 | 3,514,052 | 3,075,668 |
| 非控股權益 | 0 | -- | 0 | 0 | 0 | 0 |
300841 康華生物
按盤價 
59.020 -2.890 (-4.67%)
59.020 -2.890 (-4.67%)| 備註： | 報價延遲最少15分鐘，資料更新時間為 12/05/2026 16:30 |
